Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open‐label Study 342 (FREEDOM)
Author:
Affiliation:
1. Eisai Co., Ltd. Tokyo Japan
2. Eisai Inc. Woodcliff Lake New Jersey USA
3. Eisai Europe Ltd. Hatfield Hertfordshire UK
4. Seirei Hamamatsu General Hospital Hamamatsu Japan
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12551
Reference13 articles.
1. ILAE treatment guidelines: evidence‐based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes;Glauser T;Epilepsia,2006
2. Optimizing health outcomes in active epilepsy;Gilliam F;Neurology,2002
3. Antiepileptic drug titration and related health care resource use and costs;Fishman J;J Manag Care Spec Pharm,2018
4. Early identification of refractory epilepsy;Kwan P;N Engl J Med,2000
5. Patterns of treatment response in newly diagnosed epilepsy;Brodie MJ;Neurology,2012
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy;Seizure: European Journal of Epilepsy;2024-08
2. Effects of CYP3A5*3 genetic polymorphisms on the pharmacokinetics of perampanel in Chinese pediatric patients with epilepsy;Pharmacogenetics and Genomics;2024-05-13
3. Plasma Concentration, Efficacy, and Tolerability of Perampanel in Chinese Pediatric Patients with Epilepsy: Real-World Clinical Experience;Therapeutic Drug Monitoring;2023-09-25
4. Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study;Epilepsia Open;2023-09-25
5. Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures:A real-world experience in eastern China;Seizure: European Journal of Epilepsy;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3